Articles Tagged With:
-
Clinical Briefs
In this section: improving cardiovascular outcomes in type 2 diabetes patients; digging deeper into penicillin allergies; and treating osteoporosis.
-
Apalutamide Tablets (Erleada)
Apalutamide is indicated for the treatment of patients with non-metastatic, castration-resistant prostate cancer.
-
Providers Facilitate Transmission of Resistant Organisms
A closer look at the role providers play in the transmission of carbapenem-resistant Enterobacteriaceae.
-
Physician Burnout: A Multi-specialty Perspective
Although different specialties address the problem of physician burnout, studies suggest the most effect is gained from organizational interventions.
-
Another Reason to Get the Flu Shot Every Year
In a case-control study, among older adults, repeated vaccination for influenza was twice as effective in preventing severe influenza compared to non-severe influenza in patients who were admitted to the hospital.
-
Respiratory Distress in Pediatric Patients
Respiratory diseases are common in pediatrics, and providers need to have an in-depth knowledge of the presentation, diagnostic approach, and therapeutic options to optimize outcomes.
-
CHI Goes to Data to Improve Quality and Safety
The nation’s third-largest nonprofit healthcare system realized double-digit improvement in several key quality and safety measures in just 12 months by starting with its data.
-
CAUTIs More Expensive Than Previously Thought
Catheter-associated urinary tract infections (CAUTIs) generally are thought to cost hospitals about $1,000 each, but new research suggests the actual cost may be much higher.
-
Strict Safety Briefings Reduce CAUTIs, CLABSIs, and Falls
Daily safety briefings are not a new concept, of course, but Baptist Memorial Hospital-Memphis (TN), a flagship hospital for Baptist Memorial Healthcare System, found a way to make them particularly effective.
-
Avoid ‘Hypothetically’ and Lounge Gossip
People can let their guard down in the doctors’ lounge and chat about what they’ve seen in records or what the peer review committee is considering. That’s a very bad move, says Christopher Metzler, PhD, chief growth officer and CEO of FHWFit, a global healthcare conglomerate in Washington, DC.